Science & Technology 
Science and Technology
Science and Technology 
Fri, February 27, 2009
Thu, February 26, 2009
Phyhealth Announces Stem Cell Technology Investment
MIAMI--([ BUSINESS WIRE ])--Physicians Healthcare Management Group, Inc. (Phyhealth) (Pink Sheets: PHYH), a developer of health maintenance organizations (HMOs) in partnership with physicians, today announced that it has purchased 1.3 million common shares and 25,000 preferred shares of Bio-Matrix Scientific Group, Inc. (Bio-Matrix) (OTCBB: BMSN) in a private transaction. Bio-Matrix Scientific Group, Inc., based in San Diego, provides stem cell related services and cryogenic storage, along with the development of instruments and procedures aimed at improving quality of life issues.
Mr. Robert Trinka, Chairman and CEO of Phyhealth, stated, "Given our solid cash position, we continue to target strategic investments that will help increase value for our shareholders, while remaining focused on our core mission of delivering high quality healthcare through our innovative community health plan model. Bio-Matrix is at an important inflection point in their development, as evidenced by their recently announced strategic relationships with several leading stem cell companies, which we expect will contribute to revenue growth in the months ahead. This transaction is representative of our commitment to explore and offer leading edge healthcare technologies designed to maintain the good health of our community health plan members and provide innovative, cost effective treatments for their disorders."
"The new administration has placed a high priority on developing new healthcare treatment technologies and has announced its full support of stem cell research," continued Mr. Trinka. "We believe our relationships with companies such as Bio-Matrix, at the forefront of new healthcare solutions, will offer Phyhealth members greater access to promising new treatment technologies such as stem cell therapy."
About Bio-Matrix Scientific Group, Inc.
Bio-Matrix Scientific Group, Inc. is a biotech research and development company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market. Bio-Matrix's new 15,000 sq. ft. facility, located in the heart of San Diego's biotechnology corridor, houses the company's two secure Cryogenic Stem Cell Banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories. The company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation.
About Physicians Healthcare Management Group, Inc.
Phyhealth is a developer of fully integrated healthcare organizations in partnership with physicians. Phyhealth Plans preserve the physician-patient relationship in order to deliver high-quality affordable healthcare within its selected communities. Phyhealth offers a turnkey, prepaid health plan solution to physicians for their Medicare and other individual patients who prefer to choose their own doctor and who make their own healthcare insurance purchasing decisions. Phyhealth Plans are unique in integrating all aspects of the delivery and financing of care, including providing medical liability insurance protection through Physhield Insurance Exchange, Phyhealth's exclusive risk retention group. The Phyhealth model empowers physicians to proactively manage their patient's general health and medical care and enhances physician financial rewards by increasing practice revenues, reducing expenses and restoring the economic value (equity) of their medical practices.
Forward-Looking Statements
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Physicians Healthcare Management Group, Inc, and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Additional information is available at: [ http://www.phyhealth.com ].